Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Slides:

Advertisements

Similar presentations

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy? Wayne C. Levy,

Advertisements

Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: Application of the HeartMate II risk score

Shinichi Fukuhara, MD, Koji Takeda, MD, PhD, Paul A

The RECOVER I: A multicenter prospective study of Impella 5

Association of device surface and biomaterials with immunologic sensitization after mechanical support Isaac George, MD, Patrick Colley, BS, Mark J.

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy Francis D Pagani, MD, PhD, Keith D Aaronson, MD, David B Dyke,

Edge-to-edge mitral valve repair: the Columbia Presbyterian experience

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Dhaval Chauhan, MD, Alexis K

The days of future past Neel K. Ranganath, MD, Aubrey C. Galloway, MD

Sharven Taghavi, MD, MPH, Senthil N. Jayarajan, MD, Lynn M

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Standard versus bicaval techniques for orthotopic heart transplantation: An analysis of the United Network for Organ Sharing database Ryan R. Davies,

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure Allison P. Levin, BA, MSc,

It is still mostly about the mitral valve

Long-term patient and allograft outcomes of renal transplant recipients undergoing cardiac surgery Rodolfo V. Rocha, MD, Diana Zaldonis, MPH, Vinay Badhwar,

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

Ventricular assist device programs: design and function

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Outcomes after implantation of partial-support left ventricular assist devices in inotropic- dependent patients: Do we still need full-support assist devices?

Competing risks need to be considered in survival analysis models for cardiovascular outcomes Marianne Huebner, PhD, Martin Wolkewitz, Dr Sc Hum, Maurice.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Long-term outcome of patients on continuous-flow left ventricular assist device support Koji Takeda, MD, PhD, Hiroo Takayama, MD, PhD, Bindu Kalesan,

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Vivek Rao, MD, PhD, Mehmet C. Oz, MD, Margaret A

Support Your Specialty

Surgical management of valvular disease in patients requiring left ventricular assist device support Vivek Rao, MD, PhD, James P Slater, MD, Niloo M.

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Ranjit John, MD, Yoshifumi Naka, MD, Soon J

Fixing the supply problem

A first start for lung transplantation?

Intermediate-Term Outcome Of Mitral Reconstruction In Cardiomyopathy

Successful combined procedure of HeartMate II left ventricular assist device implantation and minimally invasive transapical aortic valve replacement

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

William L. Holman, MD, James K. Kirklin, MD, David C

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

James O. O’Neill, MB, Randall C

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Residual dissection of the brachiocephalic arteries: Significance, management, and long-term outcome Eugenio Neri, MD, Guido Sani, MD, Massimo Massetti,

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

Surgery for rheumatic tricuspid valve disease: A 30-year experience

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The future of cardiac surgery training: A survival guide

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Surgical outcomes after cardiac surgery in liver transplant recipients

The effect of ischemic time on survival after heart transplantation varies by donor age: An analysis of the United Network for Organ Sharing database

Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement Todd M. Dewey,

Cerebrovascular accidents in patients with a ventricular assist device

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure Sun Hi.

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Why arch curvature affects arch resistance

Should heart transplantation be considered as a treatment option for patients aged 70 years and older? Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.

Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Steven M Gordon, MD, Steven K Schmitt, MD, Micah Jacobs,

Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device Jiho Han, BS, Koji.

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Hari R. Mallidi, MD The Journal of Thoracic and Cardiovascular Surgery

Commentary: Evaluation of primary graft dysfunction after lung transplantation—It is time to teach an old dog new tricks! W. Hampton Gray, MD, P. Michael.

Risk factors for primary graft dysfunction after lung transplantation

Presentation transcript:

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher, BA, Neel Joshi, BA, Todd Hankinson, BA, Michelle Warren, BA, Mehmet Oz, MD, Yoshifumi Naka, MD, PhD, Donna Mancini, MD The Journal of Thoracic and Cardiovascular Surgery Volume 126, Issue 2, Pages 436-441 (August 2003) DOI: 10.1016/S0022-5223(03)00056-4

Figure 1 Kaplan-Meier survival curves for the nonemergency and emergency LVAD recipients between August 1993 and September 1999. In this figure, day 0 is defined as the day on which an LVAD was initially inserted in a patient. Survival is defined in terms of actuarial life or death. The individual circles shown in the figure represent points at which cumulative survival dropped due to patient death(s). This figure highlights the remarkable similarities in survival between the 2 groups of LVAD recipients. The Journal of Thoracic and Cardiovascular Surgery 2003 126, 436-441DOI: (10.1016/S0022-5223(03)00056-4)

Figure 2 Kaplan-Meier actuarial survival curves comparing patients receiving a transplant after LVAD support (thick line) to transplant patients who did require LVAD support (dashed line) (P = NS). The Journal of Thoracic and Cardiovascular Surgery 2003 126, 436-441DOI: (10.1016/S0022-5223(03)00056-4)